406 related articles for article (PubMed ID: 19786766)
1. Beyond tumor necrosis factor: next-generation biologic therapy for inflammatory bowel disease.
Podolsky DK
Dig Dis; 2009; 27(3):366-9. PubMed ID: 19786766
[TBL] [Abstract][Full Text] [Related]
2. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
3. Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapies.
Van Assche G; Vermeire S; Rutgeerts P
Gastroenterol Clin North Am; 2006 Dec; 35(4):743-56. PubMed ID: 17129811
[TBL] [Abstract][Full Text] [Related]
4. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
Van Assche G; Rutgeerts P
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment of inflammatory bowel diseases.
Van Assche G; Vermeire S; Rutgeerts P
Curr Opin Gastroenterol; 2005 Jul; 21(4):443-7. PubMed ID: 15930985
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Siegmund B; Zeitz M
Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
Danese S
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
[TBL] [Abstract][Full Text] [Related]
8. [The role and significance of the most important known cytokines in inflammatory bowel diseases].
Vitális Z; Altorjay I; Udvardy M
Orv Hetil; 1998 May; 139(21):1289-94. PubMed ID: 9632923
[TBL] [Abstract][Full Text] [Related]
9. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S; Angelucci E
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies in inflammatory bowel disease.
Siegmund B
Dig Dis; 2009; 27(4):465-9. PubMed ID: 19897961
[TBL] [Abstract][Full Text] [Related]
11. New cytokine therapeutics for inflammatory bowel disease.
Stokkers PC; Hommes DW
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):167-73. PubMed ID: 15588691
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone in inflammatory bowel disease.
De Pascalis B; Bianchi A; Satta MA; Lupascu A; Mentella MC; Leo D; Fiore F; Fedeli P; Pontecorvi A; Pola P; Melina D; Gasbarrini A; De Marinis L; Armuzzi A
Eur Rev Med Pharmacol Sci; 2006; 10(1):13-6. PubMed ID: 16494105
[TBL] [Abstract][Full Text] [Related]
13. Selecting appropriate anti-TNF agents in inflammatory bowel disease.
Yun L; Hanauer S
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):235-48. PubMed ID: 19485806
[TBL] [Abstract][Full Text] [Related]
14. The immune response in inflammatory bowel disease.
Brown SJ; Mayer L
Am J Gastroenterol; 2007 Sep; 102(9):2058-69. PubMed ID: 17561966
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy.
Stokkers PC; Camoglio L; van Deventer SJ
J Inflamm; 1995-1996; 47(1-2):97-103. PubMed ID: 8913936
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
Gordon JN; Di Sabatino A; Macdonald TT
Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of inflammatory bowel diseases].
Wichan P; Chojnacki J; Wojtuń S
Pol Merkur Lekarski; 2004; 17 Suppl 1():40-3. PubMed ID: 15603345
[TBL] [Abstract][Full Text] [Related]
18. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
19. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
20. Cytokine blockade in inflammatory bowel diseases.
Perrier C; Rutgeerts P
Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
